推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

NEOPLASIA 期刊收藏夹

欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此反馈;如有合作推广需求,请点此洽谈

按期刊名首写字母查看 NEOPLASIA最新评论:最后怎么样了?我也投的neoplasia,三个月了没审稿人接 (2024-09-26)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
近期推荐:
全流程投稿协助套餐服务
外科/肿瘤/心血管/神经/胃肠43本刊征稿,附文章处理费折扣!
SCI论文AI润色+人工QC服务
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


NEOPLASIA期刊基本信息Hello,您是该期刊的第27806位访客

基本信息 登录收藏
期刊名字NEOPLASIANEOPLASIA

NEOPLASIA
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.6
53人评分
我要评分

声誉
8.3

影响力
6.6

速度
9.7

期刊ISSN1476-5586
蝌蝌APP,让您与同行交流更轻松
立即下载
P-ISSN1522-8002
2024-2025最新影响因子
(数据来源于搜索引擎)
7.7 点击查看影响因子趋势图
实时影响因子 截止2025年5月19日:7.749
2024-2025自引率0.00%点击查看自引率趋势图
五年影响因子5.9
JCI期刊引文指标 1.47
h-index 115
CiteScore
2025年最新版
CiteScoreSJRSNIPCiteScore排名
11.002.1671.528
学科分区排名百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q141 / 233

期刊简介
Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.
期刊官方网站http://www.neoplasia.com/
期刊投稿格式模板
VIP专享
Word版格式模板 LaTeX版格式模板
此模板由LetPub整理,仅供参考。开通VIP可免费下载,并享1w+期刊模板资源。
此模板来自于期刊/出版社官网。开通VIP可免费下载,并享1w+期刊模板资源。
期刊投稿网址https://www.editorialmanager.com/NEO
该期刊中国学者近期发文 - NewACSL4 knockdown inhibits colorectal cancer progression through stimulating anti-tumor immunity
Author: Liu, Yiming; Jiang, Xingyu; Jing, Dongquan; Lin, Yanting; Gao, Rui; Zhao, Qixiang; Da, Huijuan; Ren, Yiming; Gao, Qiuhua; Liu, Ning; Han, Xiaoyun; Du, Juan; Gao, Xinghua
Journal: NEOPLASIA. 2025; Vol. 67, Issue , pp. -. DOI: 10.1016/j.neo.2025.101194


Exploring the full potential of Pyrotinib in HER2-positive metastatic breast cancer
Author: Tang, Wei-Zhen; Huang, Kang-jin; Liu, Tai-Hang
Journal: NEOPLASIA. 2025; Vol. 66, Issue , pp. -. DOI: 10.1016/j.neo.2025.101172


Twist1-induced suppression of oncogene-induced senescence in non-small cell lung cancer requires the transactivation domain of Twist1
Author: Lafargue, Audrey; Wang, Hailun; Chettiar, Sivarajan T.; Gajula, Rajendra P.; Shetty, Amol C.; Song, Yang; Simons, Brian W.; Khan, Muhammad Ajmal; Nguyen, Triet; Tseng, Hwai-Wei; Chang, Jinhee; Waters, Danielle N.; Chan, Aaron; Lam, Christine; Carrieri, Francesca A.; Smack, Caleb; Connis, Nick; Chowdhury, Dipanwita Dutta; Nugent, Katriana; Siddiqui, Ismaeel; Taparra, Kekoa; Rezaee, Mohammad; Zachara, Natasha; Morris, Zachary S.; Mcfarland, Christopher; Abdulkadir, Sarki Abba; Hann, Christine L.; Tran, Phuoc T
Journal: NEOPLASIA. 2025; Vol. 66, Issue , pp. -. DOI: 10.1016/j.neo.2025.101179


CYP1B1 promotes angiogenesis and sunitinib resistance in clear cell renal cell carcinoma via USP5-mediated HIF2α deubiquitination
Author: Ma, Ke; Li, Qinyu; Zhang, Yi; Wang, Jiuyi; Jia, Wei; Liu, Jihong; Liu, Bo; Li, Qiang; Wang, Qinzhang; Zeng, Kai
Journal: NEOPLASIA. 2025; Vol. 66, Issue , pp. -. DOI: 10.1016/j.neo.2025.101186


期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足NEOPLASIA的语言要求,还能让NEOPLASIA编辑和审稿人得到更好的审稿体验,让稿件最大限度地被NEOPLASIA编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(1篇)
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD3170; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:cancer、tumors、oncology research、medicine
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169
出版商Neoplasia Press
涉及的研究方向ONCOLOGY-
出版国家或地区UNITED STATES
出版语言English
出版周期
出版年份0
年文章数 133点击查看年文章数趋势图
Gold OA文章占比87.50%
研究类文章占比:
文章 ÷(文章 + 综述)
92.48%
WOS期刊JCR分区
2024-2025年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ141/326
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ144/326
中国科学院《国际期刊预警
名单(试行)》名单
2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院期刊分区
2025年3月最新升级版
点击查看中国科学院期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区2区3区
ONCOLOGY
肿瘤学
1区3区3区
中国科学院期刊分区
2023年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区4区
ONCOLOGY
肿瘤学
1区1区2区
中国科学院期刊分区
2022年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区4区
ONCOLOGY
肿瘤学
3区1区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
中科院的全球OA期刊索引(OAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-5586%5BISSN%5D
平均审稿速度网友分享经验:
12 Weeks
平均录用比例网友分享经验:
版面费/APC文章处理费信息
文章处理费:需要( USD3170; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在NEOPLASIA顺利发表。
快看看作者怎么说吧:服务好评 论文致谢(1篇)
提交文稿
期刊常用信息链接
同领域相关期刊 NEOPLASIA期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 NEOPLASIA中国科学院期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
NEOPLASIA上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2046.20
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    中国科学院期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE774012
    JOURNAL OF ETHNOPHARMACOLOGY641866
    BIOMATERIALS632445
    BIOMEDICINE & PHARMACOTHERAPY628104
    COMPUTERS IN BIOLOGY AND MEDICINE620657
    Frontiers in Pharmacology599686
    Frontiers in Immunology593583
    Frontiers in Oncology529923
    PHYTOMEDICINE512781
    COLLOIDS AND SURFACES B-BIOINTERFACES483503
  •  

    NEOPLASIA NEOPLASIA
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.ACSL4 knockdown inhibits colorectal cancer progression through stimulating anti-tumor immunity

    Author: Liu, Yiming; Jiang, Xingyu; Jing, Dongquan; Lin, Yanting; Gao, Rui; Zhao, Qixiang; Da, Huijuan; Ren, Yiming; Gao, Qiuhua; Liu, Ning; Han, Xiaoyun; Du, Juan; Gao, Xinghua
    Journal: NEOPLASIA. 2025; Vol. 67, Issue , pp. -. DOI: 10.1016/j.neo.2025.101194
        PubMed      DOI
    2.Exploring the full potential of Pyrotinib in HER2-positive metastatic breast cancer

    Author: Tang, Wei-Zhen; Huang, Kang-jin; Liu, Tai-Hang
    Journal: NEOPLASIA. 2025; Vol. 66, Issue , pp. -. DOI: 10.1016/j.neo.2025.101172
        PubMed      DOI
    3.Twist1-induced suppression of oncogene-induced senescence in non-small cell lung cancer requires the transactivation domain of Twist1

    Author: Lafargue, Audrey; Wang, Hailun; Chettiar, Sivarajan T.; Gajula, Rajendra P.; Shetty, Amol C.; Song, Yang; Simons, Brian W.; Khan, Muhammad Ajmal; Nguyen, Triet; Tseng, Hwai-Wei; Chang, Jinhee; Waters, Danielle N.; Chan, Aaron; Lam, Christine; Carrieri, Francesca A.; Smack, Caleb; Connis, Nick; Chowdhury, Dipanwita Dutta; Nugent, Katriana; Siddiqui, Ismaeel; Taparra, Kekoa; Rezaee, Mohammad; Zachara, Natasha; Morris, Zachary S.; Mcfarland, Christopher; Abdulkadir, Sarki Abba; Hann, Christine L.; Tran, Phuoc T
    Journal: NEOPLASIA. 2025; Vol. 66, Issue , pp. -. DOI: 10.1016/j.neo.2025.101179
        PubMed      DOI
    4.CYP1B1 promotes angiogenesis and sunitinib resistance in clear cell renal cell carcinoma via USP5-mediated HIF2α deubiquitination

    Author: Ma, Ke; Li, Qinyu; Zhang, Yi; Wang, Jiuyi; Jia, Wei; Liu, Jihong; Liu, Bo; Li, Qiang; Wang, Qinzhang; Zeng, Kai
    Journal: NEOPLASIA. 2025; Vol. 66, Issue , pp. -. DOI: 10.1016/j.neo.2025.101186
        PubMed      DOI
    5.EGFRvIII-driven microenvironmental fibroblast activation and transformation accelerate oral cancer progression via lipocalin-2/ STAT3 axis

    Author: Peng, Hsuan-Yu; Chang, Kwang-Yu; Chang, Wei-Min; Wu, Chia-Yu; Lee, Hsin-Lun; Chang, Yung-Chieh; Liu, Ko-Jiunn; Shiah, Shine-Gwo; Kuo, Ching-Chuan; Chang, Jang-Yang
    Journal: NEOPLASIA. 2025; Vol. 66, Issue , pp. -. DOI: 10.1016/j.neo.2025.101193
        PubMed      DOI
    6.The deubiquitinase USP7 stabilizes HER2 expression and promotes breast cancer progression

    Author: He, Xiaoyue; Xia, Xiaohong; Lei, Ziying; Tang, Mengfan; Zhang, Jiangyu; Liao, Yuning; Huang, Hongbiao
    Journal: NEOPLASIA. 2025; Vol. 66, Issue , pp. -. DOI: 10.1016/j.neo.2025.101192
        PubMed      DOI
    7.DNA-methylation eraser TET2 activates WTIP expression to suppress an AKT-dependent chemoresistance of gastric cancer [Neoplasia volume 2025 Apr 24:65:101166]

    Author: Guo, Yan; Yu, Hongyang; Li, Jinyang; Liu, Kewei; Han, Mengyi; Tang, Yuxin; Su, Li; Li, Xianfeng; Wu, Haixia; Chen, Dongfeng
    Journal: NEOPLASIA. 2025; Vol. 66, Issue , pp. -. DOI: 10.1016/j.neo.2025.101191
        PubMed      DOI
    8.SCFβ-TrCP targets Ajuba for degradation in a GSK3β-dependent manner in colorectal cancer

    Author: Li, Liangshan; Zhu, Feng; Liang, Yupei; Chen, Yuanyuan; Pan, Yongfu; Jia, Lijun; Wang, Shiwen; Zhao, Hu
    Journal: NEOPLASIA. 2025; Vol. 66, Issue , pp. -. DOI: 10.1016/j.neo.2025.101175
        PubMed      DOI
    9.Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer (vol 16, pg 665, 2014)

    Author: Zhang, Tao; Chen, Yihua; Li, Jingjie; Yang, Feifei; Wu, Haigang; Dai, Fujun; Hu, Meichun; Lu, Xiaoling; Peng, Yi; Liu, Mingyao; Zhao, Yongxiang; Yi, Zhengfang
    Journal: NEOPLASIA. 2025; Vol. 65, Issue , pp. -. DOI: 10.1016/j.neo.2025.101168
        PubMed      DOI
    10.Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer

    Author: Wu, Yuanli; Wang, Gang; Yang, Ruixue; Zhou, Duanfang; Chen, Qingjuan; Wu, Qiuya; Chen, Bo; Yuan, Lie; Qu, Na; Wang, Hongmei; Hassan, Moustapha; Zhao, Ying; Liu, Mingpu; Shen, Zhengze; Zhou, Weiying
    Journal: NEOPLASIA. 2025; Vol. 65, Issue , pp. -. DOI: 10.1016/j.neo.2025.101165
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2046.20
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    同分区等级的其他期刊名称 h-index CiteScore
    Kidney International Supplements2046.20
    Kidney International Supplements2446.20
    Annual Review of Condensed Matter Physics5140.10
    Wiley Interdisciplinary Reviews-Computational Molecular Science6238.10
    NEW ASTRONOMY REVIEWS5221.50
    SusMat00.00
    REPORTS ON PROGRESS IN PHYSICS18431.00
    Environmental Chemistry Letters5042.80
    Computational Visual Media028.50
    Nano Energy11230.40
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:
Springer发布AI审稿筛查工具:科研人怎么看?加入讨论 >>
与期刊沟通模版下载中心
VIP专享
掌握投稿全流程专业邮件模板,让您的学术沟通高效得体,显著提升论文发表效率!开通VIP可免费下载。
投稿信 (Cover Letter) 模板 回复信 (Response Letter) 模板 投稿状态查询 (Inquiry Letter) 模板
返修延期交稿 (Requesting Extension) 模板 变更作者信息申请 (Author Changes) 模板 拒稿后申诉信 (Appeal Letter) 模板
撤稿申请 (Withdrawal Request Letter) 模板 更正/勘误说明 (Corrigendum/Erratum) 模板 投稿前咨询信 (Pre-submission Inquiry) 模板
没有机构邮箱的说明 (Lack of institutional Email) 模板 更新中...

同领域作者分享投稿经验:共71


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2025 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室